Literature DB >> 6823091

Kinetics of amyloid deposition. I. The effects of amyloid-enhancing factor and splenectomy.

R Kisilevsky, L Boudreau.   

Abstract

It has long been recognized that amyloid AA deposition occurs in two phases, a predeposition and a deposition phase. The deposition phase has two distinct periods, a period of rapid deposition followed by a plateau stage. This kinetic pattern is seen in both liver and spleen and in animals in which the appearance of AA is accelerated by the administration of amyloid-enhancing factor. Amyloid-enhancing factor recipients have a shorter lag period before AA deposition is evident, but the kinetics of deposition and tissue level attained are similar to that seen in nonrecipients. It is also demonstrated that amyloid-enhancing factor activity may be generated in the liver of splenectomized animals.

Mesh:

Substances:

Year:  1983        PMID: 6823091

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  20 in total

1.  Renal amyloidosis as a late complication of Crohn's disease: a case report and review of the literature from Japan.

Authors:  Osamu Saitoh; Keishi Kojima; Tsutomu Teranishi; Ken Nakagawa; Masanobu Kayazawa; Masashi Nanri; Yutaro Egashira; Ichiro Hirata
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Complement neoantigen and vitronectin are components of plaques in amyloid AL neuropathy.

Authors:  G L Zanusso; G Moretto; B Bonetti; S Monaco; N Rizzuto
Journal:  Ital J Neurol Sci       Date:  1992-09

3.  Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition.

Authors:  Lorena Saelices; Kevin Chung; Ji H Lee; Whitaker Cohn; Julian P Whitelegge; Merrill D Benson; David S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-28       Impact factor: 11.205

4.  Are cheetahs on the run from prion-like amyloidosis?

Authors:  Byron Caughey; Gerald S Baron
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-16       Impact factor: 11.205

Review 5.  Anti-amyloid drugs: potential in the treatment of diseases associated with aging.

Authors:  R Kisilevsky
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

Review 6.  Anti-prion systems in yeast.

Authors:  Reed B Wickner
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

7.  Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice.

Authors:  Stephen J Kennel; Sally Macy; Craig Wooliver; Ying Huang; Tina Richey; Eric Heidel; Jonathan S Wall
Journal:  Amyloid       Date:  2014-01-22       Impact factor: 7.141

8.  Amyloidogenic potential of foie gras.

Authors:  Alan Solomon; Tina Richey; Charles L Murphy; Deborah T Weiss; Jonathan S Wall; Gunilla T Westermark; Per Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

9.  Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice.

Authors:  Jonathan S Wall; Tina Richey; Amy Allen; Robert Donnell; Steve J Kennel; Alan Solomon
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

10.  Induction in mice of human light-chain-associated amyloidosis.

Authors:  A Solomon; D T Weiss; M B Pepys
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.